Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis-Reference-Cited by-同舟云学术

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

Published:1995-10 Issue:8982 Volume:346 Page:1056-1059
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Feu F,García-Pagán J.C,Bosch J,Luca A,Escorsell A,Rodés J,Terés J

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Clinical manifestations and management of bleeding episodes in cirrhotics;Burroughs,1991

2. Natural history and prognosis of variceal bleeding;Burroughs;Baillière's Clin Gastroenterol,1992

3. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop;de Franchis;J Hepatol,1992

4. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis;Lebrec;N Engl J Med,1981

5. Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis;Pagliaro;Gastroenterol Int,1989

Cited by 541 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding Complications of Portal Hypertension;Clinics in Liver Disease;2024-08

2. Hepatic Venous Pressure Gradient;Clinics in Liver Disease;2024-08

3. Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis;PLOS ONE;2024-06-13

4. Management of upper gastrointestinal bleeding in advanced hepatocellular carcinoma with portal hypertension and variceal bleeding during receiving tyrosine kinase inhibitors therapy: Beyond and known frontiers;Liver Cancer International;2023-09

5. Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension;Journal of Vascular and Interventional Radiology;2023-03